title: [The prevention and treatment of cytomegalovirus infection after liver transplantation].
abstract: OBJECTIVE
  To review diagnosis and treatment experience of cytomegalovirus (CMV) infection after liver transplantation.
  
  
  METHODS
  The clinical data of 96 patients receiving liver transplantation in our hospital from January 2001 to December 2002 were analyzed retrospectively.
  
  
  RESULTS
  CMV infection occurred in 19 patients, blood IE-E antigen of CMV and PP65 antigen of CMV was detected in all the patients with CMV infection, 8 patients with CMV-IgM positivity, 3 of them presented with dyspnea, 4 with fever and 2 with jaundice, 14 patients had no symptoms of CMV infection. IE-E antigen of CMV and PP65 antigen of CMV in blood of 18 patients became negative after treatment with ganciclovir, 1 patients died from interstitial pneumonitis.
  
  
  CONCLUSIONS
  Cytomegalovirus infection after liver transplantation is associated with many factors, the key point of CMV infection is prevention actively and early treatment after operation. The detection of blood antigen of CMV is necessary for early diagnosis and guiding treatment of CMV infection, ganciclovir is effective for treatment of CMV infection.
authors.affiliation: Department of Hapatobiliary Surgery, First Affiliated Hospital, Medical College, Zhejiang University, Hangzhou 310003, China. zhengss@mail.hz.zj.cn
authors.forename: Shu-sen
authors.initials: SS
authors.lastname: Zheng
authors.forename: Zhi-jun
authors.initials: ZJ
authors.lastname: Jiang
authors.forename: Xiao
authors.initials: X
authors.lastname: Xu
authors.forename: Ting-bo
authors.initials: TB
authors.lastname: Liang
authors.forename: Wei-lin
authors.initials: WL
authors.lastname: Wang
authors.forename: Yan
authors.initials: Y
authors.lastname: Shen
authors.forename: Min
authors.initials: M
authors.lastname: Zhang
authors.forename: An-wei
authors.initials: AW
authors.lastname: Lu
mesh_terms: D000328:Adult; D000956:Antigens, Viral / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control; D012189:Retrospective Studies
chemical_list: D000956:Antigens, Viral; D000998:Antiviral Agents; D015774:Ganciclovir